TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 7 | 31 | -1 | -19 | -20 | -57 | -10 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/21/22 18:06 | 9/19/22 | APTO | Aptose Biosciences Inc. | A6 | Health | BioPrd | Biological Products, (No Diag | Payne Fletcher | A6 | O | SVP,Chie | P | 7 | 0.6775 | 0 | 10 | New | 10 | I | ||||||||||||||
2/4/19 16:52 | 2/4/19 | CBIO | Catalyst Biosciences, Inc. | Health | Drug | Pharmaceutical Preparations | Payne Fletcher | CA | O | CFO | M.d | 7 | 4.63 | 0 | 2 | 87 | 3 | D | |||||||||||||||
3/28/18 16:11 | 3/26/18 | CBIO | Catalyst Biosciences, Inc. | Health | Drug | Pharmaceutical Preparations | Payne Fletcher | CA | O | CFO | M.d | 0 | 4.63 | 0 | 0 | 4 | 2 | D | |||||||||||||||
12/18/15 17:42 | 12/17/15 | CBIO | Catalyst Biosciences, Inc. | Health | Drug | Pharmaceutical Preparations | Payne Fletcher | CA | O | CFO | P | 20 | 2.00 | 0 | 10 | 67 | 25 | I | -31 | 9 | 2 | -71 | -46 | -36 | -22 | -8 | 7 | 31 | -1 | -19 | -20 | -57 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |